Frank G. A. Jansman

University of Groningen — Netherlands

Medicine · Health Sciences

27h-index2.5kcitations113works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmaceutical Practices and Patient Outcomes(21), Cancer Treatment and Pharmacology(17), Colorectal Cancer Treatments and Studies(13), Pharmaceutical studies and practices(12), Pharmacological Effects and Toxicity Studies(10)

Publications112 total

Simplifying fractional polynomials in Bayesian network meta-analysis via variable powers
Journal of Comparative Effectiveness Research·2025Open Access
HTA148 Fractional Polynomial Survival Models in HTA: An Exploratory Review of Use and Methodological Guidance Across Global Agencies
Value in Health·2025
Mapping the epidemiology of cancer-related anemia: A systematic scoping review of global prevalence and incidence
Seminars in Oncology·2025Open Access
Optimization of vitamin K antagonist treatment: Near patient monitoring versus standard of care a parallel group clinical trial in older patients with atrial fibrillation
European Journal of Clinical Pharmacology·2025Open Access
A practical assessment protocol for clinically relevant P-glycoprotein-mediated drug-drug interactions
Frontiers in Pharmacology·2024· 4 citedOpen Access
A rapid and sensitive LC–MS/MS method for quantifying oxycodone, noroxycodone, oxymorphone and noroxymorphone in human plasma to support pharmacokinetic drug interaction studies of oxycodone
Biomedical Chromatography·2024Open Access
Drug-drug interaction perpetrators of oxycodone in patients with cancer: frequency and clinical relevance
European Journal of Clinical Pharmacology·2024· 2 citedOpen Access
2048P Frequency and clinical relevance of drug-drug interactions with oxycodone among patients with cancer
Annals of Oncology·2023Open Access
Differences in evidentiary requirements for oncology drug effectiveness assessments among six European health technology assessment bodies — can alignment be improved?
Expert Review of Pharmacoeconomics & Outcomes Research·2023· 5 citedOpen Access
Enzalutamide Reduces Oxycodone Exposure in Men with Prostate Cancer
Clinical Pharmacokinetics·2023· 7 citedOpen Access
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer
Targeted Oncology·2023· 12 citedOpen Access
Prospective evaluation of a computerized algorithm for Vitamin K antagonist drug dose calculation
Journal of Hematology and Clinical Research·2023Open Access
Effectiveness of a vitamin D regimen in deficient multiple myeloma patients and its effect on peripheral neuropathy
Supportive Care in Cancer·2023· 11 citedOpen Access
Afstellen en afstemmen van geneesmiddelen bij kanker
University of Groningen Press eBooks·2023Open Access
Lean Body Mass and Total Body Weight Versus Body Surface Area as a Determinant of Docetaxel Pharmacokinetics and Toxicity
Therapeutic Drug Monitoring·2022· 5 citedOpen Access
Differences in Evidentiary Requirements Between European Medicines Agency and European Health Technology Assessment of Oncology Drugs—Can Alignment Be Enhanced?
Value in Health·2022· 18 citedOpen Access
Clinical implications of germline variations for treatment outcome and drug resistance for small molecule kinase inhibitors in patients with non-small cell lung cancer
Drug Resistance Updates·2022· 21 citedOpen Access
Evidence- and consensus-based guidelines for drug-drug interactions with anticancer drugs; A practical and universal tool for management
Seminars in Oncology·2022· 19 citedOpen Access
Assessing the binding interaction of polystyrene sulfonate with amitriptyline in healthy volunteers: a cross-over design — The BIND study
European Journal of Clinical Pharmacology·2022· 1 citedOpen Access
Lean body mass and total body weight versus body surface area as determinant of docetaxel pharmacokinetics and toxicity
2022· 1 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

J. R. B. J. Brouwers(13), Roelof W. F. van Leeuwen(7), Ron H.J. Mathijssen(7), Teun van Gelder(6), Nielka P. van Erp(6), David M. Burger(5), Stefanie D. Krens(4), Carla M.L. van Herpen(4), J. W. Harting(4), Katja Taxis(4), Dirk Th. Sleijfer(4), Jacques C. de Graaf(4), Jules L.L.M. Coenen(4), Maarten J. Postma(4), Esther van ‘t Riet(4), Ingrid M.E. Desar(3), Richard A. van Lingen(3), G. Veerman(3), Alex L.T. Imholz(3), Rob ter Heine(3)